212 related articles for article (PubMed ID: 29273182)
1. [Peripheral arterial disease: Treatment].
Desormais I; Aboyans V; Pesteil F; Lacroix P
Presse Med; 2018 Jan; 47(1):56-61. PubMed ID: 29273182
[TBL] [Abstract][Full Text] [Related]
2. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
3. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
Armstrong EJ; Chen DC; Westin GG; Singh S; McCoach CE; Bang H; Yeo KK; Anderson D; Amsterdam EA; Laird JR
J Am Heart Assoc; 2014 Apr; 3(2):e000697. PubMed ID: 24721799
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging drug treatment strategies for peripheral arterial disease.
Essa H; Torella F; Lip GYH
Expert Opin Pharmacother; 2020 Sep; 21(13):1603-1616. PubMed ID: 32558590
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy in peripheral artery disease.
Foley TR; Waldo SW; Armstrong EJ
Vasc Med; 2016 Apr; 21(2):156-69. PubMed ID: 26823456
[TBL] [Abstract][Full Text] [Related]
6. Lack of Guideline-Directed Medical Therapy in Patients Undergoing Endovascular Procedures for Critical Limb Ischemia.
Llanos-Chea F; Jelani QU; Trejo-Paredes C; Curtis JP; Parzynski CS; Huang J; Faridi KF; Turner J; Smolderen KG; Mena-Hurtado C
J Am Coll Cardiol; 2021 Mar; 77(10):1374-1375. PubMed ID: 33706882
[No Abstract] [Full Text] [Related]
7. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
8. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
[TBL] [Abstract][Full Text] [Related]
9. Prescription of Pharmacotherapy and the Incidence of Stroke in Patients With Symptoms of Peripheral Artery Disease.
Nastasi DR; Smith JR; Moxon JV; Trollope A; Golledge J
Stroke; 2018 Dec; 49(12):2953-2960. PubMed ID: 30571405
[TBL] [Abstract][Full Text] [Related]
10. Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review.
Polonsky TS; McDermott MM
JAMA; 2021 Jun; 325(21):2188-2198. PubMed ID: 34061140
[TBL] [Abstract][Full Text] [Related]
11. Peripheral arterial disease: a review of disease awareness and management.
Watson K; Watson BD; Pater KS
Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
[TBL] [Abstract][Full Text] [Related]
12. Peripheral arterial disease.
Hiatt WR; Nehler MR
Adv Intern Med; 2001; 47():89-110. PubMed ID: 11795081
[No Abstract] [Full Text] [Related]
13. [Peripheral arterial disease with lower limb claudication: Medical treatment].
Long A; Bui HT; Journet J; Hadj Henni A
J Mal Vasc; 2009 Nov; 34(5):323-9. PubMed ID: 19713062
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease.
Hunter MR; Cahoon WD; Lowe DK
Ann Pharmacother; 2013 Nov; 47(11):1552-7. PubMed ID: 24285767
[TBL] [Abstract][Full Text] [Related]
15. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.
Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Goto S; Ohman EM; Elbez Y; Sritara P; Baumgartner I; Banerjee S; Creager MA; Bhatt DL;
Eur Heart J; 2014 Nov; 35(41):2864-72. PubMed ID: 24585266
[TBL] [Abstract][Full Text] [Related]
16. Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease.
Chen DC; Armstrong EJ; Singh GD; Amsterdam EA; Laird JR
Vasc Health Risk Manag; 2015; 11():185-92. PubMed ID: 25767395
[TBL] [Abstract][Full Text] [Related]
17. Medical therapy for peripheral arterial disease.
Simmons A; Steffen K; Sanders S
Curr Opin Cardiol; 2012 Nov; 27(6):592-7. PubMed ID: 23032711
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic therapy for peripheral arterial disease and claudication.
Hiatt WR
J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
[TBL] [Abstract][Full Text] [Related]
19. New treatments for peripheral artery disease.
Bartholomew J; Bishop GJ
Cleve Clin J Med; 2020 May; 87(5 suppl 1):21-25. PubMed ID: 32349971
[TBL] [Abstract][Full Text] [Related]
20. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
Subherwal S; Patel MR; Kober L; Peterson ED; Jones WS; Gislason GH; Berger J; Torp-Pedersen C; Fosbol EL
Circulation; 2012 Sep; 126(11):1345-54. PubMed ID: 22874581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
